ZENBIO INC.

Company Snapshot

Founded: 1995
Entity Type: Private
Region: U.S.
Headquarter: North Carolina, U.S.
Key Geographics: U.S.
Corporate Address: 3920 South Alston Ave Durham, North Carolina 27713 U.S. Tel. +1-919-547-0692 www.zen-bio.com

Company Overview

ZenBio Inc. is a leading global provider of advanced cell-based solutions and services to the life science, cosmetics and personal care communities. The company was founded in 1995. It is a pioneer in adipose derived stem cells (ASCs) and continues this legacy by providing human primary cell culture products and services. In addition, it provides reagents and contract services across a wide range of cell systems, including blood derivatives, adipocytes, stem cells, hepatocytes, and many other human primary cell types. The company provides custom cell isolations from almost any type tissue.

Zen-Bio products are manufactured under Good Laboratory Practice (GLP). Its ZenComplete platform combines cell-based products as well as consulting and research services together in a vertically integrated fashion across tissue procurement, processing, optimized media, and cell characterization.

Zen-Bio has also developed a dedicated solutions platform to assist in the emerging and diverse field of skin. ZenSkin Dermal Research Solutions encompass donor-specific tissue acquisition, full thickness skin testing and 3D skin equivalents.

Zen-Bio also provides gene expression profiling and characterization. Molecular biology and biochemistry services include multiplexed cytokine analysis, ELISA and custom assay services such as secretion, proliferation, cytotoxicity, and apoptosis.

ZENBIO INC. In Reports

3D Cell Cultures: Technologies and Global Markets

BCC Research Market Analyst says global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028 at a CAGR of 26.5% from 2023 through 2028.

Global Primary Cells Market

BCC Research Market Report for Primary Cells. Analyses of the global Primary Cells market trends, with historic market revenue with CAGRs through 2027.

Company's Business Segments

  • Products : Blood / Serum, Cell/Tissue Derived, CELLnTEC Cells and Media, Cells, Human Exosomes, Lab Ware, Media, Research Kits.
  • Services : ZenComplete Services.

Applications/End User Industries

  • Healthcare
  • Biotechnology